Organogenesis Holdings (ORGO) Asset Utilization Ratio (2017 - 2026)

Organogenesis Holdings' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.92 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 3.19% year-over-year to 0.92 in Q1 2026; TTM through Mar 2026 was 0.92, a 3.19% decrease from a year earlier, with the FY2025 full-year figure at 1.03, up 2.23% from the prior year.
• Asset Utilization Ratio retreated to 0.92 in Q1 2026 per ORGO's latest filing, from 1.02 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.05 in Q1 2022 and bottomed at 0.92 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.99 (2022), against an average of 0.99.
• Across the five-year window, Asset Utilization Ratio retreated 19.74% in 2022 and rose 8.75% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.99 in 2022, then decreased by 5.61% to 0.94 in 2023, then gained by 8.75% to 1.02 in 2024, then retreated by 0.32% to 1.02 in 2025, then decreased by 9.6% to 0.92 in 2026.
• Per Business Quant, the three latest ORGO Asset Utilization Ratio figures stand at 0.92 (Q1 2026), 1.02 (Q4 2025), and 0.96 (Q3 2025).